Eclipse Bioinnovations

Eclipse Bioinnovations is a San Diego-based biotechnology company specializing in RNA genomics and the study of RNA-protein interactions. The company was founded to commercialize the enhanced Cross-Linking and ImmunoPrecipitation (eCLIP) technology developed at the University of California, San Diego. This platform allows researchers to generate high-resolution maps of RNA-binding protein (RBP) activity, which is essential for understanding the regulatory mechanisms of the transcriptome. Eclipse Bioinnovations provides a comprehensive suite of kits and services, including miR-eCLIP and m6A-eCLIP, to support drug discovery and basic research in oncology and neurological diseases. By enabling the precise identification of therapeutic targets within RNA processing pathways, the company plays a pivotal role in the advancement of RNA-targeted medicines.